Nathalie Goemans

11.4k total citations · 4 hit papers
136 papers, 5.0k citations indexed

About

Nathalie Goemans is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Nathalie Goemans has authored 136 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 37 papers in Genetics and 26 papers in Biomedical Engineering. Recurrent topics in Nathalie Goemans's work include Muscle Physiology and Disorders (83 papers), Neurogenetic and Muscular Disorders Research (37 papers) and Cardiomyopathy and Myosin Studies (19 papers). Nathalie Goemans is often cited by papers focused on Muscle Physiology and Disorders (83 papers), Neurogenetic and Muscular Disorders Research (37 papers) and Cardiomyopathy and Myosin Studies (19 papers). Nathalie Goemans collaborates with scholars based in Belgium, United States and Italy. Nathalie Goemans's co-authors include Annemieke Aartsma‐Rus, Eugenio Mercuri, Shin’ichi Takeda, Dongsheng Duan, Gunnar Buyse, Sjef J. de Kimpe, Judith C. van Deutekom, M. van den Hauwe, Jan J.G.M. Verschuuren and Gerard Platenburg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Nathalie Goemans

125 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Duchenne muscular dystrophy

2021 708 citations Dongsheng Duan, Nathalie Goemans et al. Nature Reviews Disease Primers profile →
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051

2007 577 citations Annemieke Aartsma‐Rus, Nathalie Goemans et al. profile →
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

2011 518 citations Nathalie Goemans, Annemieke Aartsma‐Rus et al. profile →
Longitudinal effect of eteplirsen versus historical control on ambulation in D uchenne muscular dystrophy

2015 372 citations Jerry R. Mendell, Nathalie Goemans et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathalie Goemans Belgium	33	3.9k	1.1k	932	721	581	136	5.0k
Brenda Wong United States	36	2.9k 0.7×	1.1k 1.0×	914 1.0×	299 0.4×	513 0.9×	142	4.2k
Michela Guglieri United Kingdom	31	2.8k 0.7×	813 0.7×	623 0.7×	424 0.6×	372 0.6×	104	3.5k
Sonia Messina Italy	37	3.0k 0.8×	1.5k 1.3×	628 0.7×	309 0.4×	359 0.6×	114	4.3k
Thomas Voït Germany	40	3.5k 0.9×	982 0.9×	1.1k 1.1×	698 1.0×	205 0.4×	136	5.3k
Lucía Morandi Italy	43	3.7k 0.9×	835 0.7×	786 0.8×	359 0.5×	233 0.4×	143	5.2k
Adele D’Amico Italy	36	3.0k 0.8×	1.3k 1.1×	661 0.7×	318 0.4×	203 0.3×	168	4.2k
Laura E. Case United States	28	3.4k 0.9×	1.1k 0.9×	834 0.9×	524 0.7×	721 1.2×	86	6.0k
M. Tulinius Sweden	42	4.0k 1.0×	1.0k 0.9×	477 0.5×	493 0.7×	155 0.3×	126	4.9k
Akinori Nakamura Japan	38	3.3k 0.8×	630 0.6×	583 0.6×	640 0.9×	214 0.4×	144	4.5k
Anneke J. van der Kooi Netherlands	45	3.2k 0.8×	1.3k 1.1×	1.4k 1.5×	358 0.5×	140 0.2×	151	6.4k

Countries citing papers authored by Nathalie Goemans

Since Specialization

Citations

This map shows the geographic impact of Nathalie Goemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Goemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Goemans more than expected).

Fields of papers citing papers by Nathalie Goemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Goemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Goemans. The network helps show where Nathalie Goemans may publish in the future.

Co-authorship network of co-authors of Nathalie Goemans

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Goemans. A scholar is included among the top collaborators of Nathalie Goemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Goemans. Nathalie Goemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molenberghs, Geert, Nathalie Goemans, Liesbeth De Waele, et al.. (2025). Longitudinal trajectories of muscle impairments in growing boys with Duchenne muscular dystrophy. PLoS ONE. 20(3). e0307007–e0307007. 1 indexed citations

Goemans, Nathalie, et al.. (2024). Early motor, cognitive, language, behavioural and social emotional development in infants and young boys with Duchenne Muscular Dystrophy- A systematic review. European Journal of Paediatric Neurology. 52. 29–51. 1 indexed citations

Muntoni, Francesco, James Signorovitch, Gautam Sajeev, et al.. (2024). Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study. PLoS ONE. 19(7). e0304984–e0304984. 7 indexed citations

Goemans, Nathalie, et al.. (2024). Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND). Journal of Neuromuscular Diseases. 11(4). 801–814.

Papageorgiou, Eirini, Britta Hanssen, M. van den Hauwe, et al.. (2024). Gait classification for growing children with Duchenne muscular dystrophy. Scientific Reports. 14(1). 10828–10828. 3 indexed citations

Goemans, Nathalie, et al.. (2024). Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties: Insights from Clinical Practice. Journal of Neuromuscular Diseases. 11(4). 791–799.

Hauwe, M. van den, Anja Van Campenhout, Liesbeth De Waele, et al.. (2023). Predictive simulations of common gait features in children with Duchenne muscular dystrophy. Gait & Posture. 106. S213–S214. 1 indexed citations

Collin, Philippe, Nathalie Goemans, R. Jeroen Vermeulen, et al.. (2023). Psychopharmaceutical treatment for neurobehavioral problems in Duchenne muscular dystrophy: a descriptive study using real-world data. Neuromuscular Disorders. 33(7). 619–626. 4 indexed citations

Dessel, Jeroen Van, Onno C. Meijer, Hermien E. Kan, et al.. (2023). Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology. 10(12). 2324–2333. 4 indexed citations

10.

Oskoui, Maryam, Nicolas Deconinck, Elena Mazzone, et al.. (2023). Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA). Journal of the Neurological Sciences. 455. 121096–121096. 2 indexed citations

11.

Muntoni, Francesco, James Signorovitch, Gautam Sajeev, et al.. (2022). Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls. Neuromuscular Disorders. 32(4). 271–283. 19 indexed citations

12.

Servais, Laurent, Giovanni Baranello, Enrico Bertini, et al.. (2021). Pooled Safety Data from the Risdiplam Clinical Trial Development Program (4184). Neurology. 96(15_supplement). 3 indexed citations

13.

Duan, Dongsheng, Nathalie Goemans, Shin’ichi Takeda, Eugenio Mercuri, & Annemieke Aartsma‐Rus. (2021). Duchenne muscular dystrophy. Nature Reviews Disease Primers. 7(1). 13–13. 708 indexed citations breakdown →

14.

Baranello, Giovanni, Enrico Bertini, Claudia A. Chiriboga, et al.. (2020). Pooled Safety Data from the Risdiplam (RG7916) Clinical Trial Development Program (1267). Neurology. 94(15_supplement). 3 indexed citations

15.

Goemans, Nathalie, James Signorovitch, Gautam Sajeev, et al.. (2019). PRO126 A COMPOSITE PROGNOSTIC SCORE FOR TIME TO LOSS OF WALKING ABILITY IN DUCHENNE MUSCULAR DYSTROPHY (DMD). Value in Health. 22. S864–S864. 3 indexed citations

16.

Goemans, Nathalie, et al.. (2018). Injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study. European Journal of Pediatrics. 178(2). 253–258. 22 indexed citations

17.

Buyse, Gunnar, Thomas Voït, Ulrike Schara, et al.. (2016). Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy. Pediatric Pulmonology. 52(4). 508–515. 33 indexed citations

18.

Mendell, Jerry R., Nathalie Goemans, Louise R. Rodino‐Klapac, et al.. (2016). Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Clinical Update and Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) (S28.001). Neurology. 86(16_supplement). 1 indexed citations

19.

Hoste, Liesbeth, Liesbeth De Waele, Olivier Gheysens, et al.. (2015). Renal function in children and adolescents with Duchenne muscular dystrophy. Neuromuscular Disorders. 25(5). 381–387. 55 indexed citations

20.

Ferreiro, Ana, B. Estournet, C Laroche, et al.. (2001). Genetic characterisation of multi-minicore disease: identification of a first locus and evidence for genetic heterogeneity. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact